Key facts
- It has raised $410K; the latest was Early Stage VC ($410K) in Dec 2025.
- Notable investors include Innovatiefonds Noord-Holland, Vrije Universiteit Endowment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Lumeniris
- ·The full record, as it builds
Funding rounds
No funding rounds for Lumeniris are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lumeniris
Developer of medical endoscopy device technology intended to improve the visualization of disease diagnosis. The company offers a capsule-sized endoscopic imaging devices that use advanced imaging techniques to support earlier detection of esophageal conditions, including cancer, enabling healthcare professionals to diagnose disorders more efficiently than with conventional endoscopy approaches.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2025
- Employees
- 2
- Website
- lumeniris.com/
- Ownership
- Privately Held (backing)
Lumeniris doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lumeniris shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lumeniris in its N-PORT filings yet. We sweep new filings monthly.